{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:38:13Z","timestamp":1791171493631,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jaci.2011.07.056","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T08:27:42Z","timestamp":1317284862000},"page":"989-995.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":542,"title":["Mepolizumab, a humanized anti\u2013IL-5 mAb, as a treatment option for severe nasal polyposis"],"prefix":"10.1016","volume":"128","author":[{"given":"Philippe","family":"Gevaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Van Bruaene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Cattaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"Van Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Van Zele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Acke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"De Ruyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Blomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana R.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.jaci.2011.07.056_bib1","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2007","author":"Fokkens","year":"2007","journal-title":"Rhinol Suppl"},{"key":"10.1016\/j.jaci.2011.07.056_bib2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1398-9995.2006.01132.x","article-title":"Distinct features of chronic rhinosinusitis with and without nasal polyps","volume":"61","author":"Polzehl","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.07.056_bib3","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1398-9995.2006.01225.x","article-title":"Differentiation of chronic sinus diseases by measurement of inflammatory mediators","volume":"61","author":"Van Zele","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.07.056_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0091-6749(95)70298-9","article-title":"Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis","volume":"96","author":"Hamilos","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.07.056_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1067\/mai.2001.112374","article-title":"Total and specific IgE in nasal polyps is related to local eosinophilic inflammation","volume":"107","author":"Bachert","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.07.056_bib6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1365-2222.2005.02316.x","article-title":"Nasal biomarker profiles in acute and chronic rhinosinusitis","volume":"35","author":"Riechelmann","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2011.07.056_bib7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0091-6749(93)90267-J","article-title":"Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study","volume":"91","author":"Stoop","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.07.056_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2500\/105065800781329573","article-title":"Nasal polyposis: from cytokines to growth","volume":"14","author":"Bachert","year":"2000","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2011.07.056_bib9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1365-2222.1998.00380.x","article-title":"GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP)","volume":"28","author":"Hamilos","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2011.07.056_bib10","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.158.8.3902","article-title":"Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia","volume":"158","author":"Simon","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.07.056_bib11","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood.V79.12.3101.bloodjournal79123101","article-title":"Interleukin-5, eosinophils, and disease","volume":"79","author":"Sanderson","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.07.056_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1034\/j.1398-9995.2003.00110.x","article-title":"Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis","volume":"58","author":"Gevaert","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.07.056_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/ACI.0b013e3282f4178f","article-title":"Role of staphylococcal superantigens in upper airway disease","volume":"8","author":"Bachert","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.07.056_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2500\/ajr.2006.20.2887","article-title":"Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China","volume":"20","author":"Zhang","year":"2006","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2011.07.056_bib15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jaci.2009.05.017","article-title":"Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese","volume":"124","author":"Cao","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.07.056_bib16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2008.07.008","article-title":"Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease","volume":"122","author":"Zhang","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.07.056_bib17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2011.07.056_bib18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","article-title":"Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps","volume":"118","author":"Gevaert","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.07.056_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0385-8146(03)00051-8","article-title":"The effectiveness of steroid treatment in nasal polyposis","volume":"30","author":"Tuncer","year":"2003","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jaci.2011.07.056_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archotol.124.5.513","article-title":"Effect of fluticasone in severe polyposis","volume":"124","author":"Lund","year":"1998","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2011.07.056_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/xrs.732","article-title":"Random left-censoring: a statistical approach accounting for detection limits in x-ray fluorescence analysis","volume":"33","author":"Pajek","year":"2004","journal-title":"X-ray Spectrometry"},{"key":"10.1016\/j.jaci.2011.07.056_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1191\/1740774505cn119oa","article-title":"Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials","volume":"2","author":"Beunckens","year":"2005","journal-title":"Clin Trials"},{"key":"10.1016\/j.jaci.2011.07.056_bib23","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/blood-2003-10-3620","article-title":"Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome","volume":"103","author":"Klion","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.07.056_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jaci.2003.10.049","article-title":"Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes","volume":"113","author":"Garrett","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.07.056_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.otohns.2008.05.628","article-title":"A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis","volume":"139","author":"Joe","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2011.07.056_bib26","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","article-title":"A study to evaluate safety and efficacy of mepolizumab in patients with\u00a0moderate persistent asthma","volume":"176","author":"Flood-Page","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2011.07.056_bib27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.07.056_bib28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.07.056_bib29","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1056\/NEJMoa031261","article-title":"Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis","volume":"349","author":"Pl\u00f6tz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.07.056_bib30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2004.08.027","article-title":"Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700","volume":"114","author":"Kim","year":"2004","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911013248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911013248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:30:17Z","timestamp":1758789017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674911013248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0091674911013248"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2011.07.056","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13581956.14973057","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mepolizumab, a humanized anti\u2013IL-5 mAb, as a treatment option for severe nasal polyposis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2011.07.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}